Literature DB >> 3326429

The treatment of trigeminal neuralgia.

R L Busch.   

Abstract

The etiology of trigeminal neuralgia has yet to be elucidated. Thus it is not surprising that no ideal treatment is currently available. The current treatment of choice is medical; Pharmacologic management should be tried to its fullest extent. Increasing dosages and using combination drug therapies are recommended before considering a surgical approach. If drug therapy does not alleviate the pain, a surgical approach may be indicated, although 100% effectivity is not expected. Until the true etiology of trigeminal neuralgia is established, controversy will remain in the treatment of this complex disorder.

Entities:  

Mesh:

Year:  1987        PMID: 3326429      PMCID: PMC2190038     

Source DB:  PubMed          Journal:  Anesth Prog        ISSN: 0003-3006


  7 in total

1.  Studies of trigeminal nerve potentials.

Authors:  R B KING; J N MEAGHER
Journal:  J Neurosurg       Date:  1955-07       Impact factor: 5.115

2.  The medical control of tic douloureux; preliminary report on the effect of mephenesin on facial pain.

Authors:  R B KING
Journal:  J Neurosurg       Date:  1958-05       Impact factor: 5.115

3.  A study of the treatment of 637 patients with trigeminal neuralgia.

Authors:  D RUGE; R BROCHNER; L DAVIS
Journal:  J Neurosurg       Date:  1958-09       Impact factor: 5.115

4.  Effect of diphenylhydantoin on peripheral nerve.

Authors:  F MORRELL; W BRADLEY; M PTASHNE
Journal:  Neurology       Date:  1958-02       Impact factor: 9.910

5.  Chlorphenesin for trigeminal neuralgia.

Authors:  D J Dalessio
Journal:  JAMA       Date:  1973-09-24       Impact factor: 56.272

6.  Microsurgical management of trigeminal neuralgia.

Authors:  P J Jannetta
Journal:  Arch Neurol       Date:  1985-08

7.  Do phenytoin and carbamazepine depress excitation and/or facilitate inhibition?

Authors:  G H Fromm; A S Chattha; C F Terrence; J D Glass
Journal:  Eur J Pharmacol       Date:  1982-03-26       Impact factor: 4.432

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.